Skip to main content
. 2017 Nov 15;8:1527. doi: 10.1038/s41467-017-01657-3

Fig. 1.

Fig. 1

Reported HAT inhibitors perturb the La antigen conformation as assessed by ALARM NMR. Compounds tested at 400 μM final concentrations. Signal intensities (z-axis, relative units) normalized to DMSO control. Dashed border, positive readout. CPM (N-[4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl]maleimide), positive thiol-reactive compound control; fluconazole, negative thiol-reactive and aggregation compound control. Note treatment of the La antigen with compound 17 results in several new peaks independent of DTT (arrowheads). Data are representative results from one experiment performed with two technical replicates. See Table 1 for additional results and interpretations